LouisianaState Snapshot for Children

In this comparison, the NHQDR measures for Louisiana for the most recent data year and the baseline year are compared to the average of all States.

Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.

Measures Better Than Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine Total 2016 92.4 Better than Average 2008 52.7 Better than Average
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine Total 2016 94.0 Better than Average 2000 90.7 Average
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2016 97.2 Better than Average 2008 41.4 Average
Measures That Are Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine Total 2016 88.8 Average 2008 55.0 Better than Average
Children ages 19-35 months who received 3 or more doses of polio vaccine Total 2016 91.6 Average 2000 88.6 Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine Total 2016 88.3 Average 2000 65.1 Average
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine Total 2016 81.3 Average 2000 79.3 Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine Total 2016 91.2 Average 2000 87.7 Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2016 88.5 Average 2008 25.9 Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine Total 2016 26.2 Average Missing